Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Tumour-wide RNA splicing aberrations generate actionable public neoantigens

Nature(2025)10.1038/s41586-024-08552-0Source: DataRank Database

Tumour-wide RNA splicing aberrations generate actionable public neoantigens is a research paper published in Nature (2025). On theSindex it has a DataRank of 0.635. It has been cited 68 times.

N/A

0.635DataRank · unranked

Scored on demand from live citation data

Open Access68 citations

Download PDF

Cite:

Linked data & code

gen doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (27 grants)Impact (FWCI 31.13)OA: hybridTopics (81)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.635

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (31)

Nicholas Stevers ORCID,Iñaki Etxeberría ORCID,Takahide Nejo ORCID,Maggie Colton Cove ORCID,Lee H. Chen ORCID

Live enrichment

PubMed:39972144 PMC:PMC11903331 OpenAlex:https://openalex.org/W4407722089

NCI NIH HHS

Grant: P30 CA008748

NCI NIH HHS

Grant: R01 CA286507

NCI NIH HHS

Grant: T32 CA151022

NCI NIH HHS

Grant: P01 CA118816

NCI NIH HHS

Grant: P50 CA097257

NCI NIH HHS

Grant: P50 CA217694

NCI NIH HHS

Grant: R01 CA269733

NCI NIH HHS

Grant: R37 CA259177

NIH HHS

Grant: S10 OD028511

NCI NIH HHS

Grant: R01 CA222965

NIGMS NIH HHS

Grant: T32 GM008568

NINDS NIH HHS

Grant: R35 NS105068

NCI NIH HHS

Grant: R01 CA244838

NCI NIH HHS

Grant: R50 CA274229

National Institutes of Health

Grant: 5R01CA222965-05

Glioma immunotherapy targeting IDH mutation-derived epitope and immunosuppression

National Institutes of Health

Grant: 2P30CA008748-43

MOUSE GENETICS

National Institutes of Health

Grant: 5T32CA151022-07

Training Program in Translational Brain Tumor Research

National Institutes of Health

Grant: 1R01CA269733-01A1

TOX-driven CD8 T cell differentiation and dysfunction in tumors

National Institutes of Health

Grant: 5R35NS105068-05

Preclinical development of breakthrough immunotherapy for brain tumors

National Institutes of Health

Grant: 1S10OD028511-01

Illumina NovaSeq 6000 Sequencing System

National Institutes of Health

Grant: 3P01CA118816-14S1

Noninvasive Metabolic Signatures to Improve Management of Molecular Subtypes of Glioma

National Institutes of Health

Grant: 5P50CA217694-04

SPORE in Soft Tissue Sarcoma

National Institutes of Health

Grant: 5P50CA097257-12

BRAIN TUMOR SPORT GRANT

National Institutes of Health

Grant: 5T32GM008568-22

Predoctoral Training in Biomedical Sciences

National Institutes of Health

Grant: 5R37CA259177-04

Molecular mechanisms of T cell responses to a clonal neoantigen resulting from a mutated driver oncogene.

National Institutes of Health

Grant: 1R50CA274229-01

The Immortality and Evolution of Adult Brain Tumors

National Institutes of Health

Grant: 5R01CA286507-03

Novel cell therapy approaches for molecularly defined subsets of therapy-resistant melanoma

FWCI

31.13

Citation Percentile

1.0%

Citation Trend

2016

2024

2025

2026

hybridLicense: cc-by

journalhttps://doi.org/10.1038/s41586-024-08552-0

publisherhttps://doi.org/10.1038/s41586-024-08552-0

publisherhttps://www.nature.com/articles/s41586-024-08552-0.pdf

publisherhttps://www.nature.com/articles/s41586-024-08552-0

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39972144

Fields of Study

CAR-T cell therapy researchCancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses03 medical and health sciences0302 clinical medicineHumansRNA SplicingAntigens, NeoplasmNeoplasmsCD8-Positive T-LymphocytesMaleImmunotherapyReceptors, Antigen, T-CellMiceFemaleAnimalsClone Cells

MeSH Terms

AnimalsAntigens, NeoplasmClone CellsFemaleHumansImmunotherapyMaleNeoplasmsReceptors, Antigen, T-CellRNA SplicingCD8-Positive T-LymphocytesCell Line, TumorMice

Keywords

GNAS complex locusCancer researchBiologyCancerRNA splicingSomatic cellAlternative splicingImmunotherapyRNAGeneticsExonGeneMaleCD8-Positive T-Lymphocytes (mesh)General Science & Technology (science-metrix)Receptors, Antigen, T-CellRNA Splicing (mesh)CD8-Positive T-LymphocytesArticleRare Diseases (rcdc)Clinical Research (rcdc)T-Cell (mesh)MiceAntigens, NeoplasmNeoplasmsReceptorsAnimals (mesh)HumansAnimalsAntigens32 Biomedical and Clinical Sciences (for-2020)Male (mesh)3204 Immunology (for-2020)Cancer (rcdc)Humans (mesh)Neoplasms (mesh)Clone Cells (mesh)Genetics (rcdc)Immunotherapy (rcdc)Mice (mesh)2.1 Biological and endogenous factors (hrcs-rac)Cancer (hrcs-hc)Human Genome (rcdc)Clone CellsImmunotherapy (mesh)3211 Oncology and Carcinogenesis (for-2020)AntigenFemale (mesh)FemaleNeoplasm (mesh)Cancer Genomics (rcdc)

Sustainable Development Goals

SDG 0: Good health and well-being